Study | Number | Age, median (IQR) | rFVIIa dose (μg/kg) | rFVIIa doses received, number | Effect on blood-product requirements or bleeding | Thrombotic events | Deaths, number |
---|---|---|---|---|---|---|---|
Pediatric patients | |||||||
Wittenstein et al. [30] | 4 | 0.625 (0.25-9) months | 90-120 | 2 | ↓81.9% PRC between before and after one rFVIIa infusion ↓90% FFP between before and after one rFVIIa infusion | 0 | 0 |
Velik-Salchner et al. [29] | 1 | 0.5 months | 90 | 1 | Bleeding stopped | 1 (arterial) | 1 |
Dominguez et al. [24] | 2 | 11 and 13 years | 90 | 3 and 10 | ↓88.7% total blood products between 12 hours before and after rFVIIa infusion for case 1 ↓46.7% total blood products between 24 hours before and after rFVIIa infusion for case 2 | 0 | 1 |
Veldman et al. [16] | 7 | 4 (0.4-14.5) months | 83 (61-106) | 3 (2-3.5) | ↓23.1% PRC between before and after one rFVIIa infusion ↓35.3% FFP between before and after one rFVIIa infusion | 0 | 3 |
Argawal et al. [22] | 11a | 9.5 days | 36.5 ± 18.2 | 1.6 ± 7 | ↓42% PRC between before and after one rFVIIa infusion (P < 0.05) ↓59.3% FFP between before and after one rFVIIa infusion (P < .05) | 2 circuit thromboses | 3 |
Chalwin et al. [23] | 1 | 18 months | 90 | 1 | Bleeding stopped | 1 circuit thrombosis | 1 |
Guzzeta et al. [26] | 1 | 5 days | 70 | 2 | ↓66.7% PRC after the two rFVIIa doses ↓100% FFP after two rFVIIa doses | 1 extensive distal thrombotic emboli | 1 |
Schneider et al. [28] | 4b | 6.7 (1-11.2) years | 180 (146.25-180) | 2 (1.75-2) | ↓46.5% (-71.25 to -2.25) PRC between 12 hours before and after rFVIIa infusion 14.5% (-49.5 to 21.5) FFP between 24 hours before and after rFVIIa infusion | 1 stroke | 2 |
Niebler et al. [27] | 17 | 0.1 (0-14) years | 45-90 | 1.5 (1-2) | ↓50% total blood products between before and after rFVIIa infusion (P = 0.05) | 4 clinical thromboses 2 oxygenator failures 2 circuit obstructions | 12 |
Adult patients | |||||||
Bui et al. [17] | 1 | 56 years | 146.5 | 2 | ↓53.8% PRC between the 12 hours before and after rFVIIa infusion ↓16.7% FFP between 12 hours before and after rFVIIa infusion | 1 circuit thrombosis | 1 |
Brose et al. [15] | 1 | 17 years | 220 | 2 | Bleeding stopped (↓90% bleeding after rFVIIa infusion) | 0 | 0 |
Schneider et al. [28] | 5b | 48 (45.2-52) years | 90 (54-105) | 2 (1-2) | ↓61% (-79 to -47) PRC between the 12 hours before and after rFVIIa infusion ↓33% (-58 to 42) FFP between the 24 hours before and after injection of rFVIIa | 0 | 3 |
Syburra et al. [35] | 1 | 58 years | 84.7 | 1 | Bleeding stopped | 1 left atrium thrombosis | 1 |
Dunne et al. [25] | 1 | 63 years | 47 | 1 | Bleeding stopped (↓90% bleeding after rFVIIa infusion) | 0 | 0 |